Platform Small molecule


Are you applying for a project and/or looking for partners to develop, synthesize or evaluate small molecules?

Visit EATRIS Small Molecules platform which supports the preclinical and clinical development of active compounds based on the current academic discoveries of new targets and molecular mechanisms. The platform consists of 25 professional institutions working in the field of translational medicine and provides access to advanced infrastructures for screening studies, state-of-the-art in vitro analysis and integration of the latest techniques.

The contact person of the platform at UL FFA is Assoc. Prof. Dr. Žiga Jakopin.